SRC is similarly overexpressed or hyperactivated in CRC23 and moreover, BRAF-mutant CRC cells can switch between RAF/MEK/ERK and receptor tyrosine kinase signaling,32 so cell growth is only prevented when both pathways are inhibited. The gene discussed is SRC; the disease is colorectal carcinoma.